| Predicate |
Object |
| contentType |
Journal Article|Comment |
| endingPage |
e318 |
| issn |
2352-3026 |
| issueIdentifier |
5 |
| pageRange |
e317-e318 |
| publicationName |
The Lancet. Haematology |
| startingPage |
e317 |
| bibliographicCitation |
Juliusson G. Venetoclax with intensive chemotherapy in younger patients with acute myeloid leukaemia. Lancet Haematol. 2022 May;9(5):e317–8. doi: 10.1016/s2352-3026(22)00100-4. PMID: 35483394. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b95ca0994607f78a222c5c9488d58972 |
| date |
202205 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/35483394
https://doi.org/10.1016/s2352-3026%2822%2900100-4 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43133
https://portal.issn.org/resource/ISSN/2352-3026 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Venetoclax with intensive chemotherapy in younger patients with acute myeloid leukaemia |
| discusses |
http://id.nlm.nih.gov/mesh/M0020790
http://id.nlm.nih.gov/mesh/M0028488
http://id.nlm.nih.gov/mesh/M000614617 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D015470Q000188
http://id.nlm.nih.gov/mesh/D019086Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D013449Q000627
http://id.nlm.nih.gov/mesh/D006801 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49846579 |